Hyper‑IgM Syndrome (HIGM): (CD40 [TNFRSF5] for HIGM3) (Known Mutation)
Use
This test is intended for use when a specific known mutation in the CD40 (TNFRSF5) gene associated with Hyper‑IgM Syndrome type 3 has already been identified and documented by the ordering physician. It offers targeted sequencing of the coding region and flanking sequences to confirm or rule out the presence of that known familial mutation.
Special Instructions
Not provided.
Limitations
This test assesses only the specified known mutation in CD40 (TNFRSF5) and does not evaluate other possible mutations or regions; if the mutation cannot be documented, this test is not appropriate and a broader sequencing test (e.g., test 252432) should be ordered.
Methodology
Sanger
Biomarkers
CD40
Gene
LOINC Codes
- 41103-3 - Gene XXX Mut Anl Bld/T
- 41103-3 - Gene XXX Mut Anl Bld/T
Result Turnaround Time
21-28 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided
Other tests from different labs that may be relevant
